Ovarian

Science

Metabolic diseases may be driven by gut microbiome, loss of ovarian hormones

The gut microbiome interacts with the loss of female sex hormones to exacerbate metabolic disease, including weight gain, fat in…

Read More »
Business

ImmunoGen bags priority review for full approval of ovarian cancer drug (NASDAQ:IMGN)

champpixs The U.S. Food and Drug Administration has granted ImmunoGen (NASDAQ:IMGN) a priority review for its supplemental biologics license application…

Read More »
Back to top button